Experts consensus on Chinese nomenclature of Budd-Chiari syndrome

Maoheng Zu; Ke Xu; Interventional Division of Radiology Society of Chinese Medical Association

doi:10.1016/j.jimed.2021.05.003

Experts consensus on Chinese nomenclature of Budd-Chiari syndrome

J Interv Med. 2021 May 23;4(3):114-116. doi: 10.1016/j.jimed.2021.05.003. eCollection 2021 Aug.

Authors

Maoheng Zu¹, Ke Xu²; Interventional Division of Radiology Society of Chinese Medical Association

Collaborators

Interventional Division of Radiology Society of Chinese Medical Association:
Bian Ce, Cao Jianmin, Cheng Yongde, Cui Jinguo, Dang Xiaowei, Dong Jiahong, Gao Yong, Gu Jianping, Gu Yuming, Guo Chenghao, Han Xinwei, Li Linsun, Li Yanhao, Li Zhen, Liu Zuoqin, Mu Wei, Ni Caifang, Wang Zhonggao, Wang Maoqiang, Xiang Hua, Xu Hao, Xu Kai, Xu Ke, Yan Zhiping, Zhang Lin, Zhang Qingqiao, Zhang Xiaoming, Zu Maoheng

Affiliations

¹ Department of Interventional Radiology, The Affiliated Hospital of XuZhou Medical University, Xuzhou, 221000, China.
² Department of Radiology, The First Affiliated Hospital of China Medical University, Shenyang, 110000, China.

Abstract

In China, Budd-Chiari syndrome has been transliterated into six names according to the pronunciation of the letters. To standardize and unify the Chinese names of the disease, multi-disciplinary experts suggest translating Budd-Chiari syndrome into hepatic vein inferior venal cava obstruction syndrome as its Chinese name after reaching a consensus through discussion.

Keywords: Budd-Chiari Syndrome; Hepatic vein; Thrombosis.